Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Benjamin

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Cancer|October 13, 2021
There is more to soft tissue sarcomas than just grade and sizeRobert S Benjamin
The New England Journal of Medicine|September 4, 2024
A Late-Arriving but Welcome Advance in Sarcoma TherapyRobert S Benjamin
The Oncologist|June 17, 2008
SARC-CTOS imaging symposium: introduction to the problem from a clinical perspectiveRobert S Benjamin
The Lancet. Oncology|June 5, 2010
Regional hyperthermia: new standard for soft-tissue sarcomas?Robert S Benjamin
The Lancet. Oncology|February 2, 2015
Osteosarcoma: better treatment through better trial designRobert S Benjamin
Advances in Experimental Medicine and Biology|June 3, 2020
Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical PerspectiveRobert S Benjamin
BMC Medicine|May 13, 2017
Observational studies: goldmines of information on rare diseasesRobert S Benjamin
Tumori|April 22, 2017
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: a personal point of viewRobert S Benjamin
The New England Journal of Medicine|March 5, 2005
Risks and benefits of phase 1 oncology trials, revisitedRazelle Kurzrock, Robert S Benjamin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2021
Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to CardioprotectionRobert S Benjamin, Giorgio Minotti
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Cancer|October 13, 2021
There is more to soft tissue sarcomas than just grade and sizeRobert S Benjamin
The New England Journal of Medicine|September 4, 2024
A Late-Arriving but Welcome Advance in Sarcoma TherapyRobert S Benjamin
The Oncologist|June 17, 2008
SARC-CTOS imaging symposium: introduction to the problem from a clinical perspectiveRobert S Benjamin
The Lancet. Oncology|June 5, 2010
Regional hyperthermia: new standard for soft-tissue sarcomas?Robert S Benjamin
The Lancet. Oncology|February 2, 2015
Osteosarcoma: better treatment through better trial designRobert S Benjamin
Advances in Experimental Medicine and Biology|June 3, 2020
Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical PerspectiveRobert S Benjamin
BMC Medicine|May 13, 2017
Observational studies: goldmines of information on rare diseasesRobert S Benjamin
Tumori|April 22, 2017
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: a personal point of viewRobert S Benjamin
The New England Journal of Medicine|March 5, 2005
Risks and benefits of phase 1 oncology trials, revisitedRazelle Kurzrock, Robert S Benjamin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2021
Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to CardioprotectionRobert S Benjamin, Giorgio Minotti
Pageof 17